Individual holder
SAWYERS CHARLES L
US·7 granted patents·2 pending applications·72 citations·filing 2006–2012
Individually held — no corporate assignee on record.
Top patents by PatentIndex Score
9 records- 0196US8183274B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2010·Granted May 22, 2012·42 cites·40 claims
- 0295US9126941B2Treatment of hyperproliferative disorders with diarylhydantoin compoundsSAWYERS CHARLES L·Filed 2012·Granted Sep 8, 2015·26 cites·32 claims
- 0383US8697348B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571SAWYERS CHARLES L·Filed 2006·Granted Apr 15, 2014·2 cites·7 claims
- 0478US9056924B2Mutations in the BCR-ABL tyrosine kinase associated with resistance to STI-571SAWYERS CHARLES L·Filed 2008·Granted Jun 16, 2015·2 cites·42 claims
- 0574US8586291B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to ST1-571SAWYERS CHARLES L·Filed 2009·Granted Nov 19, 2013·0 cites·18 claims
- 0668US9085644B2Mutations in the Bcr-Abl tyrosine kinase associated with resistance to STI-571SAWYERS CHARLES L·Filed 2012·Granted Jul 21, 2015·0 cites·3 claims
- 0760US2012021425A1Mutations in the bcr-abl tyrosine kinase associated with resistance to sti-571SAWYERS CHARLES L·Filed 2011·Application pending·0 cites
- 0851US2010029676A1T315a and f317i mutations of bcr-abl kinase domainSAWYERS CHARLES L·Filed 2006·Application pending·0 cites
- 0946US9261498B2Biomarker for sensitivity to mTOR inhibitor therapy in kidney cancerSAWYERS CHARLES L·Filed 2006·Granted Feb 16, 2016·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when SAWYERS CHARLES L files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →